免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料，僅供一般參考，不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.

NCT：NCT04703166 · RECRUITING

NCT IDNCT04703166
狀態RECRUITING
開始日期2025-04-08
SponsorTulane University School of Medicine (OTHER)
First posted
Last updated

簡要摘要

To evaluate the progression of atrial myopathy through wearable devices and cardiac imaging.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑